National Cancer Centre Singapore

National Cancer Centre Singapore (NCCS), established in 1999, is Singapore's national referral center for cancer treatment and research. With 110 beds and JCI accreditation, NCCS treats over 65% of the nation's public-sector cancer cases, making it one of Asia's highest-volume and most experienced cancer treatment centers. The center provides a full spectrum of cancer care including medical oncology with personalized chemotherapy and targeted therapy protocols, radiation therapy using advanced linear accelerators with image-guided and intensity-modulated capabilities, surgical oncology with minimally invasive and robotic-assisted techniques, hematology for blood cancers and bone marrow transplantation, and immunotherapy including clinical trials for novel treatments. NCCS's multidisciplinary tumor boards ensure each patient receives a comprehensive, evidence-based treatment plan. As a JCI-accredited institution with active research programs in collaboration with Duke-NUS Medical School and A*STAR, NCCS is at the forefront of cancer research in Asia. The center's international patient service coordinates all aspects of overseas patient care, from initial consultation and treatment planning to accommodation and post-treatment follow-up. NCCS's world-class expertise, cutting-edge technology, and Singapore's excellent healthcare infrastructure make it a top destination for cancer patients seeking the best treatment outcomes in Asia.